Treatment of carnitine deficiency

Journal of Inherited Metabolic Disease

Volumn 26, Issue 2-3, 2003, Pages 171-180

  Winter, S C ^a  

^a CHILDREN S HOSPITAL CENTRAL CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; CARNITINE; COENZYME A; LONG CHAIN FATTY ACID;

ABDOMINAL PAIN; ALOPECIA; ARTICLE; BIOCHEMISTRY; BOLUS INJECTION; CARNITINE DEFICIENCY; CATHETER INFECTION; CLINICAL FEATURE; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG APPROVAL; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERANCE; ENZYME SYNTHESIS; FATTY ACID METABOLISM; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL DISEASE; GROWTH DISORDER; HEALTH STATUS; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; INBORN ERROR OF METABOLISM; MAJOR CLINICAL STUDY; MEDICAL RECORD; METABOLITE; MORTALITY; MUSCLE STRENGTH; PROTEIN INTAKE; RASH; RETROSPECTIVE STUDY; THEORY; UNITED STATES; URINARY EXCRETION; VOMITING;

EID: 0038042472     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024433100257     Document Type: Article

References (17)

1. Bohan TP, Helton E, McDonald I, et al (2001) Effect of L-carnitine treatment for valproate-induced hepatotoxicity. Neurology 56(10): 1405-1409.
2. Bonner CM, DeBrie KL, Hug G, et al (1995) Effects of parenteral L-carnitine supplementation on fat metabolism and nutrition in premature neonates. J Pediatr 126(2): 287-292.
3. Bonnet D, Martin D, De Lonlay P, et al (1999) Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation 100(22): 2248-2253.
4. Colonna P, Illiceto S (2000) Myocardial infarction and left ventricular remodeling: results of the CEDIM trial. Carnitine Ecocardiografia Digitalizzata Infarto Miocardico. Am Heart J 139(2 Pt 3): S 124-130.
5. Corr PB, Yamada KA (1995) Selected metabolic alterations in the ischemic heart and their contributions to arrhythmogenesis. Herz 20: 156-168.
6. den Boer ME, Wanders RJ, Morris AA, et al (2002) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics 109(1): 99-104.
7. Helton E, Darragh R, Francis, P, et al (2000) Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy. Pediatrics 105(6): 1260-1270.
8. Jackson S, Bartlett K, Land J, et al (1991) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res 29: 406-441.
9. Lango R, Smolenski RT, Narkiewicz M, et al (2001) Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass. Cardiovasc Res 51(1): 21-29.
10. Pons R, De Vivo DC (1995) Primary and secondary carnitine deficiency syndromes. J Child Neurol 10 (Supplement 2): S8-S24.
11. Rebouche CJ, Paulson DJ (1986) Carnitine metabolism and function in humans. Annu Rev Nutr 6: 41-66.
12. Rinaldo P, Yoon HR, Yu C, et al (1999) Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders. Semin Perinatol 23: 204-210.
13. Rocchiccioli F, Wanders RJA, Aubourg P, et al (1990) Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood. Pediatr Res 28: 657-662.
14. Shapira Y, Gutman A (1991) Muscle carnitine deficiency in patients using valproic acid. J Pediatr 118(4 Pt 1): 646-649.
15. Siliprandi N (1986) Transport and function of carnitine: relevance to carnitine-deficient diseases. Ann N Y Acad Sci 488: 118-126.
16. Tyni T, Palotie A, Viinikka L, et al (1997) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency with the G1528C mutation: clinical presentation of 13 patients. J Pediatr 130: 67-76.
17. Winter SC, Szabo-Aczel S, Curry CJ, et al (1987) Plasma carnitine deficiency: clinical observations in 51 pediatric patients. Am J Dis Child 141(6): 660-665.